- First drug to slow type 1 diabetes approved for NHS use in 'landmark' moment Manchester Evening News —
- Diabetes care: First drug to delay onset of type 1 diabetes made available on NHS Times Of India —
- Ground-breaking drug which can hold off diabetes for three years approved for NHS use LBC —
- One in five Brits back 'fat jab menus' at restaurants as Ozempic-style drugs change how we eat, study reveals Daily Mail —
- First drug to delay onset of type 1 diabetes made available on NHS BBC News —
- Diabetes breakthrough as NHS treatment stops disease for three years Gloucestershire Live —
- 'First of its kind' drug that delays type 1 diabetes by up to three years is approved by the NHS Daily Mail —
- Experts hail ‘new age of diabetes treatment’ as drug approved on NHS The Independent —
Teplizumab
Chemical compound
Teplizumab, sold under the brand name Tzield among others, is an anti-CD3 humanized monoclonal antibody and the first approved treatment indicated to delay the onset of stage 3 type 1 diabetes in people living with stage 2 type 1 diabetes.
NHS Approves First Drug to Delay Type 1 Diabetes
The NHS in England and Wales approved teplizumab, the world's first drug to delay the onset of type 1 diabetes for up to three years.